KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) Debt to Equity (2016 - 2024)

Exact Sciences (EXAS) has disclosed Debt to Equity for 15 consecutive years, with $0.02 as the latest value for Q1 2024.

  • On a quarterly basis, Debt to Equity fell 2.39% to $0.02 in Q1 2024 year-over-year; TTM through Mar 2024 was $0.02, a 2.39% decrease, with the full-year FY2023 number at $0.02, down 3.25% from a year prior.
  • Debt to Equity was $0.02 for Q1 2024 at Exact Sciences, roughly flat from $0.02 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.02 in Q4 2022 to a low of $0.01 in Q1 2021.
  • A 5-year average of $0.01 and a median of $0.02 in 2023 define the central range for Debt to Equity.
  • Peak YoY movement for Debt to Equity: plummeted 97.23% in 2020, then soared 159.41% in 2022.
  • Exact Sciences' Debt to Equity stood at $0.01 in 2020, then plummeted by 37.96% to $0.01 in 2021, then skyrocketed by 164.99% to $0.02 in 2022, then decreased by 3.25% to $0.02 in 2023, then rose by 0.4% to $0.02 in 2024.
  • Per Business Quant, the three most recent readings for EXAS's Debt to Equity are $0.02 (Q1 2024), $0.02 (Q4 2023), and $0.02 (Q3 2023).